- Home
- GMRE vs EYPT Comparison
GMRE vs EYPT Comparison
Compare GMRE & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMRE
- EYPT
- Stock Information
- Founded
- GMRE 2011
- EYPT 1987
- Country
- GMRE United States
- EYPT United States
- Employees
- GMRE N/A
- EYPT N/A
- Industry
- GMRE Real Estate Investment Trusts
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- GMRE Real Estate
- EYPT Industrials
- Exchange
- GMRE Nasdaq
- EYPT Nasdaq
- Market Cap
- GMRE 525.1M
- EYPT 594.5M
- IPO Year
- GMRE N/A
- EYPT 2005
- Fundamental
- Price
- GMRE $7.97
- EYPT $7.48
- Analyst Decision
- GMRE Strong Buy
- EYPT Strong Buy
- Analyst Count
- GMRE 2
- EYPT 8
- Target Price
- GMRE $10.88
- EYPT $25.71
- AVG Volume (30 Days)
- GMRE 730.8K
- EYPT 922.9K
- Earning Date
- GMRE 02-25-2025
- EYPT 03-06-2025
- Dividend Yield
- GMRE 10.54%
- EYPT N/A
- EPS Growth
- GMRE N/A
- EYPT N/A
- EPS
- GMRE N/A
- EYPT N/A
- Revenue
- GMRE $136,585,000.00
- EYPT $45,713,000.00
- Revenue This Year
- GMRE N/A
- EYPT N/A
- Revenue Next Year
- GMRE $4.89
- EYPT N/A
- P/E Ratio
- GMRE N/A
- EYPT N/A
- Revenue Growth
- GMRE N/A
- EYPT 7.50
- 52 Week Low
- GMRE $7.33
- EYPT $6.90
- 52 Week High
- GMRE $10.58
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- GMRE 48.93
- EYPT 44.49
- Support Level
- GMRE $7.33
- EYPT $7.15
- Resistance Level
- GMRE $7.77
- EYPT $8.25
- Average True Range (ATR)
- GMRE 0.22
- EYPT 0.66
- MACD
- GMRE 0.08
- EYPT -0.01
- Stochastic Oscillator
- GMRE 76.34
- EYPT 22.01
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.